|
|
||||||||
From the Departments of Neurology (Dr. Aldrich) and Psychiatry (Dr. Naylor), University of Michigan Medical Center, Ann Arbor, MI.
Although symptomatic narcolepsy, or narcolepsy due to identifiable brain lesions, was once thought to be common, there are few well-documented reported cases since the discovery of the association of REM sleep abnormalities with narcolepsy. Even fewer such reports have been accompanied by human leukocyte antigen (HLA) testing. We report 3 patients who fulfill criteria for symptomatic narcolepsy, 1 with a craniopharyngioma, the 2nd with a hypothalamic syndrome of unknown etiology, and the 3rd with obstructive hydrocephalus and a sarcoid granuloma in the region of the 3rd ventricle. The first 2 were positive for HLA-DR2 while the 3rd was negative for the HLA-DR2 and HLA-DQwl antigens. These findings suggest that diencephalic lesions can be associated with signs and symptoms of narcolepsy that are clinically indistinguishable from those of idiopathic narcolepsy, and that the HLA-DR2 antigen is not required in all cases of symptomatic narcolepsy.
Address correspondence and reprint requests to Dr. Aldrich, Department of Neurology, Taubman Center 1920/0316, University of Michigan Medical Center, 1500 East Medical Center Drive, Ann Arbor, MI 481090316.
Presented in abstract form at the Association of Professional Sleep Societies annual meeting, Washington, DC, June 1989.
Received March 23, 1989. Accepted for publication in final form May 15, 1989.
This article has been cited by other articles:
![]() |
A. Y. Avidan Narcolepsy and Idiopathic Hypersomnia ACCP Sleep Med Brd Rev, January 1, 2009; 4(0): 45 - 62. [Full Text] [PDF] |
||||
![]() |
A. Snow, E. Gozal, A. Malhotra, D. Tiosano, R. Perlman, C. Vega, E. Shahar, D. Gozal, Z.'e. Hochberg, and G. Pillar Severe Hypersomnolence After Pituitary/Hypothalamic Surgery in Adolescents: Clinical Characteristics and Potential Mechanisms Pediatrics, December 1, 2002; 110(6): e74 - 74. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ripley, S. Overeem, N. Fujiki, S. Nevsimalova, M. Uchino, J. Yesavage, D. Di Monte, K. Dohi, A. Melberg, G. J. Lammers, et al. CSF hypocretin/orexin levels in narcolepsy and other neurological conditions Neurology, December 26, 2001; 57(12): 2253 - 2258. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Malik, B. F. Boeve, L. E. Krahn, and M. H. Silber Narcolepsy associated with other central nervous system disorders Neurology, August 14, 2001; 57(3): 539 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Siegel, R. Nienhuis, S. Gulyani, S. Ouyang, M. F. Wu, E. Mignot, R. C. Switzer, G. McMurry, and M. Cornford Neuronal Degeneration in Canine Narcolepsy J. Neurosci., January 1, 1999; 19(1): 248 - 257. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tafti, S. Nishino, M. S. Aldrich, W. Liao, W. C. Dement, and E. Mignot Major Histocompatibility Class II Molecules in the CNS: Increased Microglial Expression at the Onset of Narcolepsy in a Canine Model J. Neurosci., August 1, 1996; 16(15): 4588 - 4595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Dyken, T. Yamada, D. C. Lin-Dyken, P. Seaba, and M. Yeh Diagnosing Narcolepsy Through the Simultaneous Clinical and Electrophysiologic Analysis of Cataplexy Arch Neurol, May 1, 1996; 53(5): 456 - 460. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |